Research Article
Levofloxacin Use in Patients with Suspected Tuberculosis in a Community Hospital, Thailand: A Pilot Study
Table 4
Clinical data of 6 patients with chronic hepatitis and 2 patients who died before the availability of AFB results.
| Patient number | Gender | Number of AFB test | Pre-AFB regimen | AFB results | Post-AFB regimen |
| 1 | Female | 2 | Levofloxacin + ethambutol + amikacin | All negative | Died before AFB results | 2 | Female | 3 | Levofloxacin + ethambutol + amikacin | All negative | Continued levofloxacin | 3 | Male | 3 | Levofloxacin + ethambutol + amikacin | All negative | Discontinued levofloxacin | 4 | Male | 3 | Levofloxacin + ethambutol + amikacin | All negative | Discontinued levofloxacin | 5 | Male | 2 | Levofloxacin + ethambutol + streptomycin | All negative | Continued levofloxacin | 6 | Male | 2 | Levofloxacin + ethambutol + amikacin | All negative | Continued levofloxacin | 7 | Male | 1 | Levofloxacin + ethambutol + amikacin | All negative | Died before AFB results |
|
|
Patient 1 had chronic hepatitis and died before AFB results.
|